Atea cut to Underweight at Morgan Stanley citing concerns over oral COVID-19 drug
January 06 2022 - 12:07PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Atea Pharmaceuticals (NASDAQ:AVIR)
Historical Stock Chart
From Apr 2024 to May 2024
Atea Pharmaceuticals (NASDAQ:AVIR)
Historical Stock Chart
From May 2023 to May 2024